This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Chelsea Ariane Huff: Innovator in Pharmaceutical Development
Introduction
Chelsea Ariane Huff is a notable inventor based in King of Prussia, Pennsylvania. She has made significant contributions to the field of pharmaceutical development, particularly in the area of NRF2 activators. Her work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents
Chelsea holds a patent for "Bisaryl amides as NRF2 activators." This invention relates to bisaryl amide analogs, pharmaceutical compositions containing them, and their use as NRF2 activators. Specifically, the invention focuses on bisaryl heterocycles of Formula (I), which have potential therapeutic applications.
Career Highlights
Chelsea is associated with GlaxoSmithKline Intellectual Property Development Limited, where she applies her expertise in pharmaceutical innovation. Her role involves researching and developing new compounds that can lead to significant advancements in healthcare.
Collaborations
Some of her notable coworkers include James Francis Callahan and Vincent J Colandrea. Their collaborative efforts contribute to the success of their projects and the advancement of their shared goals in pharmaceutical research.
Conclusion
Chelsea Ariane Huff exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the development of NRF2 activators, highlight her role as a key player in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile